U.S., Oct. 1 -- An application to own the trademark for 'HYSORPTASE' has been filed on Nov. 11, 2024.
Owner(s):
Shanghai Bao Pharmaceuticals Co.,Ltd.; No.28 Luoxin Road,, , CHINA
Goods and/or Services:
For: Medicines for human purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; pharmaceutical preparations for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabete...